Mp78-10 the Influence of Genetic Variants on Clinical Outcomes and Toxic Effects in Patients With Advanced Renal Cell Carcinoma Treated With Sorafenib: A Multi-Center Research

Journal of Urology - Netherlands
doi 10.1016/j.juro.2016.02.1966
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated With Sorafenib

Cancer Research
Cancer ResearchOncology
2018English

Attenuation of Liver Stiffness in Sorafenib-Treated Patients With Advanced Hepatocellular Carcinoma

Hepatoma Research
2017English

Mp03-13 Clinical Outcomes in Patients With Metastatic Papillary Renal Cell Carcinoma: A Japanese Multi-Institutional Study

Journal of Urology
Urology
2016English

A Phase I, Open-Label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2014English

Efficacy of Cryoablation Combined With Sorafenib for the Treatment of Advanced Renal Cell Carcinoma

International Journal of Hyperthermia
MedicineCancer ResearchRadiologicalPhysiologyUltrasound Technology
2019English

Cerebrovascular Ischemic Events in Patients With Advanced Renal Cell Carcinoma Treated With Anti-Angiogenic Tyrosine Kinase Inhibitors: A Report on Two Cases With Different Outcomes

Journal of Medical Cases
2015English

Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Journal of Hepatocellular Carcinoma
2015English

Critical Appraisal of Sorafenib in the Treatment of Chinese Patients With Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2014English

Genetic Variants of EGF and VEGF Predict Prognosis of Patients With Advanced Esophageal Squamous Cell Carcinoma

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy